In most other tumors, including melanoma, colorectal cancer, and lung cancer, the immunogenic features of the TIME (tumor infiltration by CD8+ T cells; inflamed phenotype) are considered to be markers of good prognosis [24,25], while they are associated with poor prognosis in RCC [20]. This evidence concerns the gene CD8A and lung carcinoma.